Skip to main content

MARSHALL WACE, LLP

Position in GH — Guardant Health, Inc.

CIK 1318757 LONDON, X0

Position in GH

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$27,778,054
+$10,291,074 QoQ
Shares Held
185,150
+8.1% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#97
of 593 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $872,920,182 across 27 Diagnostics & Research names. GH ranks #10 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GH

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,778,054 185,150
2025-12-31 $17,486,980 171,206
2025-09-30 $15,076,798 241,306
2025-03-31 $7,520,305 176,533
2024-12-31 $980,196 32,085
2024-03-31 $2,473,083 119,878
2023-06-30 $12,649,321 353,333
2023-03-31 $482,864 20,600
2022-12-31 $217,436 7,994
2021-12-31 $395,479 3,954
2021-06-30 $41,753,174 336,204
2021-03-31 $7,218,971 47,291
2020-12-31 $122,034,152 946,882
2020-09-30 $104,132,235 931,582
2020-06-30 $123,161,992 1,518,082
2020-03-31 $47,669,596 684,908